Cobe Hemoflo Blood Tubing Sets
510(k) K801211
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK801211 | Date14 Jul 1980 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- FJK
- Device Class
- Class II
- Regulation
- 21 CFR Part 876.5820
- Advisory Committee
- Gastroenterology, Urology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Cobe Hemoflo Blood Tubing Sets are sterile, single-use blood tubing assemblies designed for use in hemodialysis and related extracorporeal blood circuits. These sets incorporate tubing with and without anti-regurgitation valves to facilitate controlled blood flow during therapeutic procedures, ensuring compatibility with extracorporeal blood processing systems.
Supplied as sterile, single-use devices, these sets are intended for use in clinical settings such as hemodialysis units and urology/gastroenterology procedures. They are classified under FDA regulation 876.5820 and include multiple reference codes (e.g., FJK) for identification. The sets were granted FDA 510(k) clearance under K801211 in 1980, with a traditional review process and no third-party involvement.
Other devices from Cobe Laboratories, Inc.
Questions
AI-generated answers, 19 Sep 2026
What clinical procedures are these blood tubing sets primarily intended for, and why are they designed this way?
The Cobe Hemoflo Blood Tubing Sets are primarily designed for hemodialysis and related extracorporeal blood circuits, including procedures in urology and gastroenterology. They incorporate tubing with and without anti-regurgitation valves to ensure controlled blood flow during therapeutic procedures, which is critical for maintaining patient safety and system integrity during blood processing.
Are these tubing sets reusable, and if not, what does that mean for clinical workflows?
No, these tubing sets are sterile, single-use only, meaning each set is intended for one-time use in a single patient procedure. This design minimizes infection risks and ensures consistent performance, but it requires clinicians to manage inventory and waste disposal accordingly, as they cannot be reused or reprocessed.
How should these tubing sets be stored, and what precautions should be taken before use?
Since they are sterile and single-use, these sets should be stored in their original, unopened packaging in a clean, dry environment away from direct sunlight or extreme temperatures. The packaging must remain intact until immediately before use to preserve sterility. Always check the expiration date and inspect for damage before opening.
What does the FDA’s 510(k) clearance (K801211) from 1980 indicate about the device’s regulatory path?
The FDA’s 510(k) clearance (K801211) confirms that the Cobe Hemoflo Blood Tubing Sets were determined to be substantially equivalent to a legally marketed device at the time of submission. This traditional review process (without third-party involvement) means the device met FDA requirements for safety and effectiveness as of 1980, though ongoing compliance with current regulations remains the responsibility of the manufacturer and user.
Do these sets come in multiple sizes or configurations, and how might that affect selection for a procedure?
While the exact sizes or model variations aren’t detailed in the data, the product codes (e.g., FJK) and the mention of tubing with and without anti-regurgitation valves suggest there may be multiple configurations. Clinicians should select the appropriate set based on the specific extracorporeal blood circuit requirements (e.g., flow rate, valve needs) and compatibility with their dialysis machine or procedural setup.